The patient buddy app can potentially prevent hepatic encephalopathy-related readmissions. - PubMed - NCBI
Liver Int. 2017 Jun 15. doi: 10.1111/liv.13494. [Epub ahead of print]
The patient buddy app can potentially prevent hepatic encephalopathy-related readmissions.
Ganapathy D1,
Acharya C1,
Lachar J1,
Patidar K1,
Sterling RK1,
White MB1,
Ignudo C2,
Bommidi S2,
DeSoto J2,
Thacker LR3,
Matherly S1,
Shaw J1,
Siddiqui MS1,
Puri P1,
Sanyal AJ1,
Luketic V1,
Lee H1,
Stravitz RT1,
Bajaj JS1.
Abstract
BACKGROUND & AIMS:
Readmissions are a major burden in cirrhosis. A proportion of readmissions in cirrhosis, especially because of hepatic encephalopathy (HE) could be avoided through patient and caregiver engagement. We aimed to define the feasibility of using the Patient Buddy App and its impact on 30-day readmissions by engaging and educating cirrhotic inpatients and caregivers in a pilot study. METHODS:
Cirrhotic inpatients with caregivers were enrolled and followed for 30 days post-discharge. On separately assigned devices loaded with Patient Buddy, they were trained on entering medication adherence, daily sodium intake and weights, and weekly cognitive (EncephalApp_Stroop) and fall-risk assessment and were educated regarding cirrhosis-related symptoms. These were monitored daily through a Patient Buddy loaded iPad by the clinical team. The App sent automatic alerts between patient/caregivers and clinical team regarding adherence and critical values. At 30 days, total, and HE-related admissions were analysed as well as the feasibility and feedback regarding educational values. RESULTS:
Forty patients and 40 caregivers were enrolled. Seventeen patients were readmitted within 30-days but none for HE. Eight potential HE-related readmissions were prevented through App-generated alerts that encouraged early outpatient interventions. Caregivers and patients were concordant in data entry but six did not complete data entries. Most respondents rated the App favourably for its educational value. CONCLUSIONS:
In this proof-of-concept trial, the use of Patient Buddy is feasible in recently discharged patients with cirrhosis and their caregivers. Eight HE-related readmissions were potentially avoided after the use of the App. © 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
KEYWORDS:
caregiver; cirrhosis; falls; stroop app
No hay comentarios:
Publicar un comentario